ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination

NHS England North East And Yorkshire · compiled

Tender information last checkedLast checked 30 Sept 2026, 08:28.

Opportunity overview

NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: Yorkshire & Humber: • Lot 1 - North Lincolnshire and North East Lincolnshire • Lot 2 - Hull • Lot 3 - East Riding • Lot 4 - Leeds • Lot 5 - Bradford • Lot 6 - Kirklees • Lot 7 - Wakefield • Lot 8 - Barnsley • Lot 9 - Doncaster North East and North Cumbria: • Lot 10 - Newcastle Upon Tyne

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Lincolnshire Community Health Services NHS Trust

No match
Published award value
Value not stated
Awarded
Not supplied
Contract signed
19 Aug 2025
Award ID
052590-2025-Lot 1 - North Lincolnshire and North East Lincolnshire-1
Status
active
Identifier
GB-NHS RY5
Location
Lincoln, UKE13, LN5 7JH, United Kingdom

Solutions 4 Health

2 award entriesMatched by number
Published award value
Value not stated
Awarded
Not supplied
Contract signed
19 Aug 2025
Status
active
Identifier
GB-COH 06475161
Location
Reading, UKJ1, RG1 8EQ, United Kingdom
View 2 award IDs

052590-2025-Lot 9 - Doncaster-9, 052590-2025-Lot 10 - Newcastle Upon Tyne-10

City Health Care Partnership CIC

2 award entriesMatched by number
Published award value
Value not stated
Awarded
Not supplied
Contract signed
19 Aug 2025
Status
active
Identifier
GB-COH 06273905
Location
Hull, UKE11, HU3 4AE, United Kingdom
View 2 award IDs

052590-2025-Lot 2 - Hull-2, 052590-2025-Lot 3 - East Riding-3

Leeds Community Healthcare NHS Trust

Match pending…
Published award value
Value not stated
Awarded
Not supplied
Contract signed
19 Aug 2025
Award ID
052590-2025-Lot 4 - Leeds-4
Status
active
Identifier
GB-NHS RY6
Location
Leeds, UKE42, LS11 0DL, United Kingdom

Locala Community Partnerships CIC

2 award entriesMatched by number
Published award value
Value not stated
Awarded
Not supplied
Contract signed
19 Aug 2025
Status
active
Identifier
GB-COH 07584906
Location
Liversedge, UKE4, WF15 6LP, United Kingdom
View 2 award IDs

052590-2025-Lot 5 - Bradford-5, 052590-2025-Lot 6 - Kirklees-6

Spectrum Community Health CIC

2 award entriesMatched by number
Published award value
Value not stated
Awarded
Not supplied
Contract signed
19 Aug 2025
Status
active
Identifier
GB-COH 07300133
Location
Wakefield, UKE45, WF1 5RH, United Kingdom
View 2 award IDs

052590-2025-Lot 7 - Wakefield-7, 052590-2025-Lot 8 - Barnsley-8

Classification

  • CPV85140000 — Miscellaneous health services

Lots

  • Lot 1 - North Lincolnshire and North East LincolnshireValue not stated
  • Lot 10 - Newcastle Upon TyneValue not stated
  • Lot 2 - HullValue not stated
  • Lot 3 - East RidingValue not stated
  • Lot 4 - LeedsValue not stated
  • Lot 5 - BradfordValue not stated
  • Lot 6 - KirkleesValue not stated
  • Lot 7 - WakefieldValue not stated
  • Lot 8 - BarnsleyValue not stated
  • Lot 9 - DoncasterValue not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
NHSE1088
Status
complete
Procurement Method
limited
Main Procurement Category
services
Procurement Method Details
Award procedure without prior publication of a call for competition
Why this procedure was chosen
The Relevant Authority intends to award this contract under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. There were no Conflicts of Interest.

Covered By

GPA

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Id
85140000
Scheme
CPV
Description
Miscellaneous health services

Procedure reasons

Entry 1
Id
D_OUTSIDE_SCOPE
Scheme
TED_PT_AWARD_CONTRACT_WITHOUT_CALL
Description
The procurement falls outside the scope of application of the directive

Lots and requirements

Entry 1
Id
1
Title
Lot 1 - North Lincolnshire and North East Lincolnshire
Status
cancelled
Has Options
Yes
Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1).

Options

Description
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1).

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 2
Id
2
Title
Lot 2 - Hull
Status
cancelled
Has Options
Yes
Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2).

Options

Description
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: • Lot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2).

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 3
Id
3
Title
Lot 3 - East Riding
Status
cancelled
Has Options
Yes
Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026.

Options

Description
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026.

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 4
Id
4
Title
Lot 4 - Leeds
Status
cancelled
Has Options
Yes
Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years.

Options

Description
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years.

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 5
Id
5
Title
Lot 5 - Bradford
Status
cancelled
Has Options
Yes
Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033.

Options

Description
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033.

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 6
Id
6
Title
Lot 6 - Kirklees
Status
cancelled
Has Options
Yes
Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032.

Options

Description
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032.

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 7
Id
7
Title
Lot 7 - Wakefield
Status
cancelled
Has Options
Yes
Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031.

Options

Description
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031.

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 8
Id
8
Title
Lot 8 - Barnsley
Status
cancelled
Has Options
Yes
Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028.

Options

Description
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028.

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 9
Id
9
Title
Lot 9 - Doncaster
Status
cancelled
Has Options
Yes
Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: • Lot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027.

Options

Description
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027.

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 10
Id
10
Title
Lot 10 - Newcastle Upon Tyne
Status
cancelled
Has Options
Yes
Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: North East and North Cumbria: • Lot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030.

Options

Description
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030.

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery Location

Description
Lot 1 - North Lincolnshire and North East Lincolnshire

Delivery locations

Entry 1
Region
UKE13

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 2
Id
2
Related Lot
2

Delivery Location

Description
Lot 2 - Hull

Delivery locations

Entry 1
Region
UKE11

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 3
Id
3
Related Lot
3

Delivery Location

Description
Lot 3 - East Riding

Delivery locations

Entry 1
Region
UKE12

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 4
Id
4
Related Lot
4

Delivery Location

Description
Lot 4 - Leeds

Delivery locations

Entry 1
Region
UKE42

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 5
Id
5
Related Lot
5

Delivery Location

Description
Lot 5 - Bradford

Delivery locations

Entry 1
Region
UKE41

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 6
Id
6
Related Lot
6

Delivery Location

Description
Lot 6 - Kirklees

Delivery locations

Entry 1
Region
UKE4

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 7
Id
7
Related Lot
7

Delivery Location

Description
Lot 7 - Wakefield

Delivery locations

Entry 1
Region
UKE45

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 8
Id
8
Related Lot
8

Delivery Location

Description
Lot 8 - Barnsley

Delivery locations

Entry 1
Region
UKE31

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 9
Id
9
Related Lot
9

Delivery Location

Description
Lot 9 - Doncaster

Delivery locations

Entry 1
Region
UKE31

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 10
Id
10
Related Lot
10

Delivery Location

Description
Lot 10 - Newcastle Upon Tyne

Delivery locations

Entry 1
Region
UKC22

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services

Buyer, suppliers and contacts

Organisation 1
Id
GB-NHS-(Q72)
Name
NHS England North East And Yorkshire

Roles

buyer

Address

Region
UKE
Locality
Leeds
Postal Code
LS11 5BD
Country Name
United Kingdom
Street Address
City Office Park 3 Leeds City Office Park Holbeck

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Id
(Q72)
Scheme
GB-NHS
Legal Name
NHS England North East And Yorkshire

Contact

Organisation 2
Id
GB-NHS-RY5
Name
Lincolnshire Community Health Services NHS Trust

Roles

supplier

Address

Region
UKE13
Locality
Lincoln
Postal Code
LN5 7JH
Country Name
United Kingdom
Street Address
Beech House, Witham Park, Waterside South

Details

Scale
large

Identifier

Id
RY5
Scheme
GB-NHS
Legal Name
Lincolnshire Community Health Services NHS Trust
Organisation 3
Id
GB-COH-06273905
Name
City Health Care Partnership CIC

Roles

supplier

Address

Region
UKE11
Locality
Hull
Postal Code
HU3 4AE
Country Name
United Kingdom
Street Address
5 Beacon Way

Details

Scale
large

Identifier

Id
06273905
Scheme
GB-COH
Legal Name
City Health Care Partnership CIC
Organisation 4
Id
GB-NHS-RY6
Name
Leeds Community Healthcare NHS Trust

Roles

supplier

Address

Region
UKE42
Locality
Leeds
Postal Code
LS11 0DL
Country Name
United Kingdom
Street Address
White Rose Office Park, Building 3 Millshaw Park Lane

Details

Scale
large

Identifier

Id
RY6
Scheme
GB-NHS
Legal Name
Leeds Community Healthcare NHS Trust
Organisation 5
Id
GB-COH-07584906
Name
Locala Community Partnerships CIC

Roles

supplier

Address

Region
UKE4
Locality
Liversedge
Postal Code
WF15 6LP
Country Name
United Kingdom
Street Address
Eddercliffe Health Centre, Bradford Road,

Details

Scale
large

Identifier

Id
07584906
Scheme
GB-COH
Legal Name
Locala Community Partnerships CIC
Organisation 6
Id
GB-COH-07300133
Name
Spectrum Community Health CIC

Roles

supplier

Address

Region
UKE45
Locality
Wakefield
Postal Code
WF1 5RH
Country Name
United Kingdom
Street Address
1 Navigation Walk, Hebble Wharf,

Details

Scale
large

Identifier

Id
07300133
Scheme
GB-COH
Legal Name
Spectrum Community Health CIC
Organisation 7
Id
GB-COH-06475161
Name
Solutions 4 Health

Roles

supplier

Address

Region
UKJ1
Locality
Reading
Postal Code
RG1 8EQ
Country Name
United Kingdom
Street Address
Head Office Unit 1 Thames Court Richfield Avenue

Details

Scale
large

Identifier

Id
06475161
Scheme
GB-COH
Legal Name
Solutions 4 Health
Organisation 8
Id
GB-FTS-159290
Name
NHS England North East And Yorkshire

Roles

reviewBody

Address

Locality
Leeds
Postal Code
LS11 5BD
Country Name
United Kingdom
Street Address
City Office Park 3 Leeds City Office Park Holbeck

Details

Identifier

Legal Name
NHS England North East And Yorkshire

Contact

Award information

Award 1
Id
052590-2025-Lot 1 - North Lincolnshire and North East Lincolnshire-1
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-NHS-RY5
Name
Lincolnshire Community Health Services NHS Trust
Award 2
Id
052590-2025-Lot 2 - Hull-2
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-06273905
Name
City Health Care Partnership CIC
Award 3
Id
052590-2025-Lot 3 - East Riding-3
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-06273905
Name
City Health Care Partnership CIC
Award 4
Id
052590-2025-Lot 4 - Leeds-4
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-NHS-RY6
Name
Leeds Community Healthcare NHS Trust
Award 5
Id
052590-2025-Lot 5 - Bradford-5
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-07584906
Name
Locala Community Partnerships CIC
Award 6
Id
052590-2025-Lot 6 - Kirklees-6
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-07584906
Name
Locala Community Partnerships CIC
Award 7
Id
052590-2025-Lot 7 - Wakefield-7
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-07300133
Name
Spectrum Community Health CIC
Award 8
Id
052590-2025-Lot 8 - Barnsley-8
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-07300133
Name
Spectrum Community Health CIC
Award 9
Id
052590-2025-Lot 9 - Doncaster-9
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-06475161
Name
Solutions 4 Health
Award 10
Id
052590-2025-Lot 10 - Newcastle Upon Tyne-10
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-06475161
Name
Solutions 4 Health

Contracts and changes

Entry 1
Id
052590-2025-Lot 1 - North Lincolnshire and North East Lincolnshire-1
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
052590-2025-Lot 1 - North Lincolnshire and North East Lincolnshire-1
Date Signed
20 Aug 2025, 00:00
Entry 2
Id
052590-2025-Lot 2 - Hull-2
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
052590-2025-Lot 2 - Hull-2
Date Signed
20 Aug 2025, 00:00
Entry 3
Id
052590-2025-Lot 3 - East Riding-3
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
052590-2025-Lot 3 - East Riding-3
Date Signed
20 Aug 2025, 00:00
Entry 4
Id
052590-2025-Lot 4 - Leeds-4
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
052590-2025-Lot 4 - Leeds-4
Date Signed
20 Aug 2025, 00:00
Entry 5
Id
052590-2025-Lot 5 - Bradford-5
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
052590-2025-Lot 5 - Bradford-5
Date Signed
20 Aug 2025, 00:00
Entry 6
Id
052590-2025-Lot 6 - Kirklees-6
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
052590-2025-Lot 6 - Kirklees-6
Date Signed
20 Aug 2025, 00:00
Entry 7
Id
052590-2025-Lot 7 - Wakefield-7
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
052590-2025-Lot 7 - Wakefield-7
Date Signed
20 Aug 2025, 00:00
Entry 8
Id
052590-2025-Lot 8 - Barnsley-8
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
052590-2025-Lot 8 - Barnsley-8
Date Signed
20 Aug 2025, 00:00
Entry 9
Id
052590-2025-Lot 9 - Doncaster-9
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
052590-2025-Lot 9 - Doncaster-9
Date Signed
20 Aug 2025, 00:00
Entry 10
Id
052590-2025-Lot 10 - Newcastle Upon Tyne-10
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
052590-2025-Lot 10 - Newcastle Upon Tyne-10
Date Signed
20 Aug 2025, 00:00

Recorded locations

  • Buyer location · Leeds · UKE · LS11 5BD · United Kingdom
  • Delivery location · UKC22
  • Delivery location · UKE11
  • Delivery location · UKE12
  • Delivery location · UKE13
  • Delivery location · UKE31
  • Delivery location · UKE4
  • Delivery location · UKE41
  • Delivery location · UKE42
  • Delivery location · UKE45

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-0590ce-2025-08-29T16:21:16+01:00compiled ·